ZA936350B - The use of IL-4 receptor for the therapy, prophylaxis and diagnosis of allergic, veral, parasitic and bacterial diseases and of fungal infections. - Google Patents

The use of IL-4 receptor for the therapy, prophylaxis and diagnosis of allergic, veral, parasitic and bacterial diseases and of fungal infections.

Info

Publication number
ZA936350B
ZA936350B ZA936350A ZA936350A ZA936350B ZA 936350 B ZA936350 B ZA 936350B ZA 936350 A ZA936350 A ZA 936350A ZA 936350 A ZA936350 A ZA 936350A ZA 936350 B ZA936350 B ZA 936350B
Authority
ZA
South Africa
Prior art keywords
veral
prophylaxis
allergic
parasitic
diagnosis
Prior art date
Application number
ZA936350A
Inventor
Karlheinz Enssle
Roland Kurrle
Leander Lauffer
Friederich-Robert Seiler
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of ZA936350B publication Critical patent/ZA936350B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1793—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA936350A 1992-08-31 1993-08-30 The use of IL-4 receptor for the therapy, prophylaxis and diagnosis of allergic, veral, parasitic and bacterial diseases and of fungal infections. ZA936350B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4228941 1992-08-31

Publications (1)

Publication Number Publication Date
ZA936350B true ZA936350B (en) 1994-03-25

Family

ID=6466831

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA936350A ZA936350B (en) 1992-08-31 1993-08-30 The use of IL-4 receptor for the therapy, prophylaxis and diagnosis of allergic, veral, parasitic and bacterial diseases and of fungal infections.

Country Status (2)

Country Link
KR (1) KR100332138B1 (en)
ZA (1) ZA936350B (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4264490A (en) * 1979-05-11 1981-04-28 Radiation Dynamics, Inc. Composition of a polyethylene and isobutylene copolymer

Also Published As

Publication number Publication date
KR100332138B1 (en) 2002-08-28
KR940003565A (en) 1994-03-12

Similar Documents

Publication Publication Date Title
CA2105101A1 (en) The use of the il-4 receptor for the therapy, prophylaxis and diagnosis of allergic, viral, parasitic and bacterial diseases and of fungal infections
CA2260145A1 (en) Use of l-acetylcarnitine, l-isovalerylcarnitine, l-propionylcarnitine for increasing the levels of igf-1
AU2845492A (en) Dipyridamole for the treatment of proliferative diseases
MD970199A (en) Induction of a cytotoxic T-lymphocytic answer The invention relates to the medicine, particularly to the immunology and can be used for treatment of bacterial and parasitic infections, tumors and other diseases. The summary of the invention consists in the induction of a cytotoxic T-lymphocytic answer to human and animals by means of a composition consisting of an antigene and an antigenic formulati
WO2001045679A3 (en) Use of chemotherapeutic agents for topical treatment
NO308854B1 (en) Therapeutic Compounds, Pharmaceutically Acceptable Salts and Formulations Containing the Compounds, and Uses thereof
AU2160492A (en) Treatment of human diseases involving dysregulation or dysfunction of the nervous system
AU6916694A (en) Novel treatments for allergic diseases
AU6801694A (en) The treatment of small animals
WO1992012715A3 (en) The use of loperamide and related compounds for treatment of respiratory disease symptoms
AU4774597A (en) Use of 1-hydroxy-2-pyridones for the treatment of skin infections
WO1997018790A3 (en) Therapeutic and diagnostic agents for the treatment of microbial infections
AU3328693A (en) Treatment of fungal infections
AU2807492A (en) Use of misoprostol for the treatment of allergy
AU4094293A (en) Methods for the diagnosis of fungal infections
AU7595194A (en) Use of antigenic substances for the prophylaxis or therapy of disorders and diseases within the gastrointestinal tract of animals and humans
AUPQ344799A0 (en) Treatment of respiratory diseases and infections
AU4859596A (en) Imidazo{1,2-a}pyridines for the treatment of cns and cardiac diseases
ZA936350B (en) The use of IL-4 receptor for the therapy, prophylaxis and diagnosis of allergic, veral, parasitic and bacterial diseases and of fungal infections.
AU3833700A (en) Agents and methods for the control of fungal and bacterial diseases
CY2339B1 (en) Use of aminopurine antiviral agents for the treatment and prophylaxis of latent herpesvirus infections.
AU5381890A (en) Interferon for the use in the prevention or treatment of swine pneumonia or related bacterial diseases
AU7750794A (en) Use of hydroxychloroquine for treatment of graft-versus-host disease
CA2366510A1 (en) Early detection of inflammation and infection using infrared thermography
AU3439897A (en) Pharmaceutical formulations containing colostrum and their use